• locale

  Australia

• market

  STOCKS

• industry

  Biotechnology

• website

  www.neuroscientific.com

• ipo date

  Jul 27, 2018

NeuroScientific Biopharmaceuticals Limited develops therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative dementia and Alzheimer's disease, and degenerative conditions of the optic nerve. The company was incorporated in 2002 and is based ...Show More

*Estimate based on analyst consensus